Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

Completed · Phase 4

Conditions studied: Rheumatoid Arthritis, Plaque Psoriasis

In brief

The study will estimate the preference of rheumatoid arthritis (RA) and Plaque Psoriasis (PsO) patients who self inject etanercept for one of two experimental autoinjectors.

Key facts

Study ID
NCT01875991
Run by
Amgen
People needed
217
Starts
2013-06-05
Expected to finish
2014-03-04
Last updated by the study team
2018-09-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.